barr 904 (Tamoxifen 20 mg)
Pill imprint barr 904 has been identified as Tamoxifen citrate 20 mg.
Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, metastatic; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for barr 904 (Tamoxifen 20 mg)
- 20 mg
- 10.00 mm
- Prescription only
- Drug Class:
Selective estrogen receptor modulators
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Barr Laboratories, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00591-2233||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
Note: Inactive ingredients may vary.